IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Brooks Laboratories Limited is an Pharmaceutical based company, located in Punjab, Brooks Laboratories Limited IPO size was 63.00 Cr. and was issued at 100.00 per share. The share of Brooks Laboratories Limited were listed at 60.20 per share and are currently trading at 139.77 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Brooks Laboratories operates in Pharmaceutical and Business Of Pharmaceutical Contract Research & Manufacturing. The Issue is listed on BSE,NSE in Sep, 2011. Brooks Laboratories IPO size was 63.00 Cr. with Issue price of 100.00 .
Merchant Banker(s) of Brooks Laboratories IPO: D And A Financial Services Private Limited
Brooks Laboratories IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Brooks Laboratories IPO listed at a listing price of 60.20 against the offer price of 100.00.
The current market price of Brooks Laboratories is 139.77.
Why Us?
